These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
389 related articles for article (PubMed ID: 28579536)
21. Dietary lipids do not contribute to the higher hepatic triglyceride levels of fructose- compared to glucose-fed mice. Nunes PM; Wright AJ; Veltien A; van Asten JJ; Tack CJ; Jones JG; Heerschap A FASEB J; 2014 May; 28(5):1988-97. PubMed ID: 24500922 [TBL] [Abstract][Full Text] [Related]
24. A dual sugar challenge test for lipogenic sensitivity to dietary fructose. Hudgins LC; Parker TS; Levine DM; Hellerstein MK J Clin Endocrinol Metab; 2011 Mar; 96(3):861-8. PubMed ID: 21252253 [TBL] [Abstract][Full Text] [Related]
25. Fatty Acid Synthase Inhibitor TVB-2640 Reduces Hepatic de Novo Lipogenesis in Males With Metabolic Abnormalities. Syed-Abdul MM; Parks EJ; Gaballah AH; Bingham K; Hammoud GM; Kemble G; Buckley D; McCulloch W; Manrique-Acevedo C Hepatology; 2020 Jul; 72(1):103-118. PubMed ID: 31630414 [TBL] [Abstract][Full Text] [Related]
26. Isocaloric Substitution of Dietary Carbohydrate Intake with Fat Intake and MRI-Determined Total Volumes of Visceral, Subcutaneous and Hepatic Fat Content in Middle-Aged Adults. Meisinger C; Rospleszcz S; Wintermeyer E; Lorbeer R; Thorand B; Bamberg F; Peters A; Schlett CL; Linseisen J Nutrients; 2019 May; 11(5):. PubMed ID: 31126078 [TBL] [Abstract][Full Text] [Related]
27. Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease. Lambert JE; Ramos-Roman MA; Browning JD; Parks EJ Gastroenterology; 2014 Mar; 146(3):726-35. PubMed ID: 24316260 [TBL] [Abstract][Full Text] [Related]
29. Fructose drives de novo lipogenesis affecting metabolic health. Geidl-Flueck B; Gerber PA J Endocrinol; 2023 May; 257(2):. PubMed ID: 36753292 [TBL] [Abstract][Full Text] [Related]
30. Nutritional regulation of hepatic de novo lipogenesis in humans. Cross E; Dearlove DJ; Hodson L Curr Opin Clin Nutr Metab Care; 2023 Mar; 26(2):65-71. PubMed ID: 36892956 [TBL] [Abstract][Full Text] [Related]
31. Metabolic effects of the dietary monosaccharides fructose, fructose-glucose, or glucose in mice fed a starch-containing moderate high-fat diet. Bouwman LMS; Nieuwenhuizen AG; Swarts HJM; Piga R; van Schothorst EM; Keijer J Physiol Rep; 2020 Feb; 8(3):e14350. PubMed ID: 32026655 [TBL] [Abstract][Full Text] [Related]
32. Altered In Vivo Lipid Fluxes and Cell Dynamics in Subcutaneous Adipose Tissues Are Associated With the Unfavorable Pattern of Fat Distribution in Obese Adolescent Girls. Nouws J; Fitch M; Mata M; Santoro N; Galuppo B; Kursawe R; Narayan D; Vash-Margita A; Pierpont B; Shulman GI; Hellerstein M; Caprio S Diabetes; 2019 Jun; 68(6):1168-1177. PubMed ID: 30936147 [TBL] [Abstract][Full Text] [Related]
33. Effect of Restriction of Foods with High Fructose Corn Syrup Content on Metabolic Indices and Fatty Liver in Obese Children. Ibarra-Reynoso LDR; López-Lemus HL; Garay-Sevilla ME; Malacara JM Obes Facts; 2017; 10(4):332-340. PubMed ID: 28787728 [TBL] [Abstract][Full Text] [Related]
34. Sex Differences in Hepatic Low WS; Cornfield T; Charlton CA; Tomlinson JW; Hodson L Nutrients; 2018 Sep; 10(9):. PubMed ID: 30205493 [TBL] [Abstract][Full Text] [Related]
35. Postprandial de novo lipogenesis and metabolic changes induced by a high-carbohydrate, low-fat meal in lean and overweight men. Marques-Lopes I; Ansorena D; Astiasaran I; Forga L; Martínez JA Am J Clin Nutr; 2001 Feb; 73(2):253-61. PubMed ID: 11157321 [TBL] [Abstract][Full Text] [Related]
36. High hepatic SCD1 activity is associated with low liver fat content in healthy subjects under a lipogenic diet. Silbernagel G; Kovarova M; Cegan A; Machann J; Schick F; Lehmann R; Häring HU; Stefan N; Schleicher E; Fritsche A; Peter A J Clin Endocrinol Metab; 2012 Dec; 97(12):E2288-92. PubMed ID: 23015656 [TBL] [Abstract][Full Text] [Related]
37. Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease. Smith GI; Shankaran M; Yoshino M; Schweitzer GG; Chondronikola M; Beals JW; Okunade AL; Patterson BW; Nyangau E; Field T; Sirlin CB; Talukdar S; Hellerstein MK; Klein S J Clin Invest; 2020 Mar; 130(3):1453-1460. PubMed ID: 31805015 [TBL] [Abstract][Full Text] [Related]
38. Ethnic differences in pancreatic fat accumulation and its relationship with other fat depots and inflammatory markers. Lê KA; Ventura EE; Fisher JQ; Davis JN; Weigensberg MJ; Punyanitya M; Hu HH; Nayak KS; Goran MI Diabetes Care; 2011 Feb; 34(2):485-90. PubMed ID: 21270204 [TBL] [Abstract][Full Text] [Related]
39. Conversion of Sugar to Fat: Is Hepatic de Novo Lipogenesis Leading to Metabolic Syndrome and Associated Chronic Diseases? Schwarz JM; Clearfield M; Mulligan K J Am Osteopath Assoc; 2017 Aug; 117(8):520-527. PubMed ID: 28759094 [TBL] [Abstract][Full Text] [Related]
40. Effects of 4-week very-high-fructose/glucose diets on insulin sensitivity, visceral fat and intrahepatic lipids: an exploratory trial. Silbernagel G; Machann J; Unmuth S; Schick F; Stefan N; Häring HU; Fritsche A Br J Nutr; 2011 Jul; 106(1):79-86. PubMed ID: 21396140 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]